Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

3 Small-Caps That Might Be Acquisition Candidates

TheMotleyFool

0 0

3 Small-Caps That Might Be Acquisition CandidatesPhoto, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

A lot of small biotechs are fantastic buys right now. With Big Pharma sitting on a lot of cash, we might start seeing some smart acquisitions later this year.

We asked a trio of contributors to pick the biotechs they're feeling most bullish about as potential buyout candidates in 2022. Their choices: OptimizeRx (NASDAQ: OPRX), Affimed (NASDAQ: AFMD), and Blueprint Medicines (NASDAQ: BPMC).

Image source: Getty Images.

Source Fool.com

Like: 0

OPRX

Teilen